NCT02892123 2024-11-27Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersJazz PharmaceuticalsPhase 1 Completed279 enrolled
NCT00215462 2009-04-28Vinorelbine in Unresectable or Metastatic Esophageal and Gastric AdenocarcinomaDana-Farber Cancer InstitutePhase 2 Completed32 enrolled